Erin Dean

1.5k total citations
88 papers, 649 citations indexed

About

Erin Dean is a scholar working on Oncology, General Health Professions and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Erin Dean has authored 88 papers receiving a total of 649 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 12 papers in General Health Professions and 11 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Erin Dean's work include CAR-T cell therapy research (9 papers), Ovarian cancer diagnosis and treatment (6 papers) and Healthcare Systems and Challenges (5 papers). Erin Dean is often cited by papers focused on CAR-T cell therapy research (9 papers), Ovarian cancer diagnosis and treatment (6 papers) and Healthcare Systems and Challenges (5 papers). Erin Dean collaborates with scholars based in United States, Canada and China. Erin Dean's co-authors include Frederick L. Locke, Michael D. Jain, Francis Lee, C. L. Gupta, Danny Lovatsis, Alon D. Altman, Robert Lotocki, Yoganand Balagurunathan, Farhad Khimani and Edwin A. Kroeger and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Erin Dean

70 papers receiving 633 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erin Dean United States 12 275 164 114 80 72 88 649
Regan A. Howard United States 7 303 1.1× 36 0.2× 71 0.6× 103 1.3× 24 0.3× 11 564
Keith Arthur Canada 19 299 1.1× 62 0.4× 261 2.3× 14 0.2× 39 0.5× 34 873
Evangelos Lianos Greece 10 154 0.6× 34 0.2× 351 3.1× 29 0.4× 22 0.3× 26 632
Daniel David Australia 11 221 0.8× 224 1.4× 77 0.7× 14 0.2× 16 0.2× 29 588
Sebastian Berlit Germany 13 79 0.3× 37 0.2× 143 1.3× 12 0.1× 9 0.1× 64 670
Kimio Hashimoto Japan 17 141 0.5× 71 0.4× 258 2.3× 5 0.1× 18 0.3× 102 856
Maryam Rezvani United States 13 65 0.2× 20 0.1× 384 3.4× 11 0.1× 57 0.8× 34 847
Yao‐Lung Chang Taiwan 20 46 0.2× 92 0.6× 456 4.0× 7 0.1× 98 1.4× 110 1.7k
Jørn Jensen Denmark 14 93 0.3× 176 1.1× 379 3.3× 66 0.8× 44 0.6× 31 789
Tian Dai United States 16 379 1.4× 49 0.3× 50 0.4× 4 0.1× 41 0.6× 40 905

Countries citing papers authored by Erin Dean

Since Specialization
Citations

This map shows the geographic impact of Erin Dean's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erin Dean with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erin Dean more than expected).

Fields of papers citing papers by Erin Dean

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erin Dean. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erin Dean. The network helps show where Erin Dean may publish in the future.

Co-authorship network of co-authors of Erin Dean

This figure shows the co-authorship network connecting the top 25 collaborators of Erin Dean. A scholar is included among the top collaborators of Erin Dean based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erin Dean. Erin Dean is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wingard, John R., Ji‐Hyun Lee, Zeina Al‐Mansour, et al.. (2025). Randomized Noninferiority Trial of a Liberalized Diet Versus the Neutropenic Diet in Hematopoietic Stem-Cell Transplant Patients and Patients With Acute Leukemia. Journal of Clinical Oncology. 44(4). 300–310.
3.
Balagurunathan, Yoganand, Jin Qi, Zachary Thompson, et al.. (2024). Radiomic features of PET/CT imaging of large B cell lymphoma lesions predicts CAR T cell therapy efficacy. Frontiers in Oncology. 14. 1485039–1485039. 2 indexed citations
4.
Cline, Christina, Zeina Al‐Mansour, Ji‐Hyun Lee, et al.. (2024). A phase ib clinical trial of oral ciprofloxacin and etoposide in subjects with resistant acute myeloid leukemia. Leukemia & lymphoma. 65(10). 1502–1510.
5.
Choi, Jung Woo, Erin Dean, Hong Lu, et al.. (2023). Repeatability of metabolic tumor burden and lesion glycolysis between clinical readers. Frontiers in Immunology. 14. 994520–994520. 5 indexed citations
6.
Mayrand, Marie‐Hélène, Céline Bouchard, Shannon Salvador, et al.. (2023). Canadian Guideline on the Management of a Positive Human Papillomavirus Test and Guidance for Specific Populations. Current Oncology. 30(6). 5652–5679. 3 indexed citations
7.
Dean, Erin, Matthew J. Frank, Nasheed Hossain, et al.. (2023). Circulating tumor DNA adds specificity to PET after axicabtagene ciloleucel in large B-cell lymphoma. Blood Advances. 7(16). 4608–4618. 16 indexed citations
8.
9.
Frank, Matthew J., Nasheed Hossain, Ali Bukhari, et al.. (2021). Monitoring of Circulating Tumor DNA Improves Early Relapse Detection After Axicabtagene Ciloleucel Infusion in Large B-Cell Lymphoma: Results of a Prospective Multi-Institutional Trial. Journal of Clinical Oncology. 39(27). 3034–3043. 87 indexed citations
10.
Dean, Erin, et al.. (2021). Neuropsychiatric assessment and management of the ICU survivor. Cleveland Clinic Journal of Medicine. 88(12). 669–679. 8 indexed citations
11.
Dean, Erin, Rahul Mhaskar, Hong Lü, et al.. (2020). High metabolic tumor volume is associated with decreased efficacy of axicabtagene ciloleucel in large B-cell lymphoma. Blood Advances. 4(14). 3268–3276. 146 indexed citations
12.
Eiriksson, Lua, Erin Dean, Alexandra Sebastianelli, et al.. (2020). Guideline No. 408: Management of Gestational Trophoblastic Diseases. Journal of Obstetrics and Gynaecology Canada. 43(1). 91–105.e1. 18 indexed citations
13.
Altman, Alon D., et al.. (2020). Response to Multi-Line Chemotherapy in Non-Serous Epithelial Ovarian Cancer. Journal of Obstetrics and Gynaecology Canada. 42(10). 1217–1222. 1 indexed citations
14.
Dean, Erin, et al.. (2017). Posttraumatic Reconstruction of the Foot and Ankle in the Face of Active Infection. Orthopedic Clinics of North America. 48(2). 249–258. 3 indexed citations
15.
Khimani, Farhad, Erin Dean, Brian C. Betts, et al.. (2017). Predictors of overall survival among patients treated with sirolimus/tacrolimus vs methotrexate/tacrolimus for GvHD prevention. Bone Marrow Transplantation. 52(7). 1003–1009. 8 indexed citations
16.
Lambert, Pascal, Donna Turner, Robert Lotocki, et al.. (2017). Examining the Selection Criteria of Neoadjuvant Chemotherapy Patients. Journal of Obstetrics and Gynaecology Canada. 40(5). 595–603. 2 indexed citations
17.
Altman, Alon D., Pascal Lambert, Donna Turner, et al.. (2017). Examining the Effects of Time to Diagnosis, Income, Symptoms, and Incidental Detection on Overall Survival in Epithelial Ovarian Cancer. International Journal of Gynecological Cancer. 27(8). 1637–1644. 20 indexed citations
18.
19.
Dean, Erin. (2012). Smoother, faster..... PubMed. 26(52). 16–9. 1 indexed citations
20.
Holland, R, José Arlindo Otoboni Filho, Pedro Felício Estrada Bernabé, et al.. (1998). Effect of root canal filling material and level of surgical injury on periodontal healing in dogs. Dental Traumatology. 14(5). 199–205. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Regan A. Howard Breakdown of academic impact, for papers by Keith Arthur Breakdown of academic impact, for papers by Evangelos Lianos Breakdown of academic impact, for papers by Daniel David Breakdown of academic impact, for papers by Sebastian Berlit Breakdown of academic impact, for papers by Kimio Hashimoto Breakdown of academic impact, for papers by Maryam Rezvani Breakdown of academic impact, for papers by Yao‐Lung Chang Breakdown of academic impact, for papers by Jørn Jensen Breakdown of academic impact, for papers by Tian Dai
Rankless by CCL
2026